{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:48:47Z","timestamp":1794491327589,"version":"4.9.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":67,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004761","name":"the Natural Science Foundation of Hunan Province","doi-asserted-by":"crossref","award":["2025JJ60490"],"award-info":[{"award-number":["2025JJ60490"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002858","name":"the China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["2025M772003"],"award-info":[{"award-number":["2025M772003"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2024ZD0527700\/2024ZD0527704"],"award-info":[{"award-number":["2024ZD0527700\/2024ZD0527704"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82471365 and 82271369"],"award-info":[{"award-number":["82471365 and 82271369"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Clinical Research Fund of the National Clinical Research Center for Geriatric Disease","award":["2023LNJJ14 and 2020LNJJ16"],"award-info":[{"award-number":["2023LNJJ14 and 2020LNJJ16"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and objective<\/jats:title>\n                    <jats:p>The atherogenic index of plasma (AIP) reflects atherogenic dyslipidemia and insulin resistance, whereas the frailty index (FI) quantifies cumulative physiological deficits across multiple organ systems. Although both the AIP and FI are independently associated with cardiometabolic multimorbidity (CMM), the joint impact of the atherogenic index of plasma-frailty index (AIPFI) on the risk of CMM remains unclear. In this study, the associations between baseline levels, cumulative AIPFI and longitudinal changes of AIPFI and the incidence of CMM were evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data were obtained from the China Health and Retirement Longitudinal Study (CHARLS). A total of 7995 participants were included in the baseline analysis, and 4,483 participants with repeated biomarker measurements in 2012 and 2015 were included in the longitudinal analysis. AIPFI was calculated via the following formula: AIPFI\u2009=\u2009AIP \u00d7 FI. Multivariate Cox proportional hazards models and restricted cubic splines were applied to evaluate the associations of AIPFI with the incidence of CMM. K-means clustering characterized longitudinal AIPFI patterns. The clinical prediction model was performed in both the training and validation cohorts, as validated by receiver operating characteristic curve analysis, calibration curve analysis, and decision curve analysis. The shapley additive explanations (SHAP) method was employed to provide further explanation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 7995 participants were included and followed for a median of 9.0 years, during which 747 (9.3%) incident CMMs occurred. Across quartiles of the AIPFI, the risk of CMM increased progressively, with adjusted HR of 2.46 (95% CI 1.77\u20133.43) for Q4 compared with those for Q1. In longitudinal analyses (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20094,483), participants in cluster 2, with persistently high and increasing AIPFI values, presented increased risks of CMM (HR 1.54, 95% CI 1.19\u20132.01). An elevated cumulative AIPFI was associated with an increased incidence of CMM (HR 1.01, 95% CI 1.01\u20131.01). The RCS revealed a significant positive nonlinear relationship between the baseline AIPFI and cumulative AIPFI with the risk of CMM (all\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05, and all P for nonlinear values\u2009&lt;\u20090.05). SHAP model analysis revealed hypertension, heart disease, and AIPFI as the most influential predictors.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Both baseline and longitudinal changes in the AIPFI were independently associated with the risk of CMM. The incorporation of longitudinal monitoring of the AIPFI into routine health evaluations may enhance population-level CMM risk prediction and support more effective prevention strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12933-026-03235-8","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T11:35:31Z","timestamp":1780745731000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Associations of cumulative exposure and dynamic trajectories of the combined atherogenic and frailty index with incident cardiometabolic multimorbidity: a longitudinal analysis based on the China Health and Retirement Longitudinal Study (CHARLS)"],"prefix":"10.1186","volume":"25","author":[{"given":"Xianjing","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bi","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghuan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanting","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,6]]},"reference":[{"issue":"6","key":"3235_CR1","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1097\/CM9.0000000000001985","volume":"135","author":"J Fan","year":"2022","unstructured":"Fan J, Sun Z, Yu C, Guo Y, Pei P, Yang L, Chen Y, Du H, Sun D, Pang Y, et al. Multimorbidity patterns and association with mortality in 0.5 million Chinese adults. Chin Med J (Engl). 2022;135(6):648\u201357.","journal-title":"Chin Med J (Engl)"},{"issue":"3","key":"3235_CR2","doi-asserted-by":"publisher","first-page":"e024476","DOI":"10.1136\/bmjopen-2018-024476","volume":"9","author":"D Zhang","year":"2019","unstructured":"Zhang D, Tang X, Shen P, Si Y, Liu X, Xu Z, Wu J, Zhang J, Lu P, Lin H, et al. Multimorbidity of cardiometabolic diseases: prevalence and risk for mortality from one million Chinese adults in a longitudinal cohort study. BMJ Open. 2019;9(3):e024476.","journal-title":"BMJ Open"},{"issue":"1","key":"3235_CR3","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1038\/s41467-024-46686-x","volume":"15","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Zhuang Z, Li Y, Xiao W, Song Z, Huang N, Wang W, Dong X, Jia J, Clarke R, et al. Elevated blood remnant cholesterol and triglycerides are causally related to the risks of cardiometabolic multimorbidity. Nat Commun. 2024;15(1):2451.","journal-title":"Nat Commun"},{"issue":"1","key":"3235_CR4","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12933-025-02819-0","volume":"24","author":"Z Tian","year":"2025","unstructured":"Tian Z, Yang L, Li Y, Huang Y, Yang J, Xue F. Associations of different insulin resistance-related indices with the incidence and progression trajectory of cardiometabolic multimorbidity: a prospective cohort study from UK biobank. Cardiovasc Diabetol. 2025;24(1):257.","journal-title":"Cardiovasc Diabetol"},{"key":"3235_CR5","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.jad.2023.08.067","volume":"340","author":"X Zhu","year":"2023","unstructured":"Zhu X, Ding L, Zhang X, Xiong Z. Association of cognitive frailty and abdominal obesity with cardiometabolic multimorbidity among middle-aged and older adults: a longitudinal study. J Affect Disord. 2023;340:523\u20138.","journal-title":"J Affect Disord"},{"issue":"3","key":"3235_CR6","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/s44161-024-00444-w","volume":"3","author":"M Kivim\u00e4ki","year":"2024","unstructured":"Kivim\u00e4ki M, Partridge L. Biological aging as a predictor of cardiometabolic multimorbidity. Nat Cardiovasc Res. 2024;3(3):256\u20137.","journal-title":"Nat Cardiovasc Res"},{"issue":"1","key":"3235_CR7","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12933-023-01886-5","volume":"22","author":"B Yin","year":"2023","unstructured":"Yin B, Wu Z, Xia Y, Xiao S, Chen L, Li Y. Non-linear association of atherogenic index of plasma with insulin resistance and type 2 diabetes: a cross-sectional study. Cardiovasc Diabetol. 2023;22(1):157.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3235_CR8","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12933-024-02163-9","volume":"23","author":"X Wu","year":"2024","unstructured":"Wu X, Qiu W, Yang H, Chen YJ, Liu J, Zhao G. Associations of the triglyceride-glucose index and atherogenic index of plasma with the severity of new-onset coronary artery disease in different glucose metabolic states. Cardiovasc Diabetol. 2024;23(1):76.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3235_CR9","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s12933-025-02784-8","volume":"24","author":"X Wang","year":"2025","unstructured":"Wang X, Wen P, Liao Y, Wu T, Zeng L, Huang Y, Song X, Xiong Z, Deng L, Li D, et al. Association of atherogenic index of plasma and its modified indices with stroke risk in individuals with cardiovascular-kidney-metabolic syndrome stages 0\u20133: a longitudinal analysis based on CHARLS. Cardiovasc Diabetol. 2025;24(1):254.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3235_CR10","doi-asserted-by":"publisher","first-page":"e3764","DOI":"10.1002\/dmrr.3764","volume":"40","author":"D Xiao","year":"2024","unstructured":"Xiao D, Sun H, Chen L, Li X, Huo H, Zhou G, Zhang M, He B. Assessment of six surrogate insulin resistance indexes for predicting cardiometabolic multimorbidity incidence in Chinese middle-aged and older populations: Insights from the China health and retirement longitudinal study. Diabetes Metab Res Rev. 2024;40(1):e3764.","journal-title":"Diabetes Metab Res Rev"},{"key":"3235_CR11","doi-asserted-by":"publisher","first-page":"101789","DOI":"10.1016\/j.arr.2022.101789","volume":"84","author":"D Kaskirbayeva","year":"2023","unstructured":"Kaskirbayeva D, West R, Jaafari H, King N, Howdon D, Shuweihdi F, Clegg A, Nikolova S. Progression of frailty as measured by a cumulative deficit index: a systematic review. Ageing Res Rev. 2023;84:101789.","journal-title":"Ageing Res Rev"},{"key":"3235_CR12","unstructured":"Yao T, Liu C, Wang K, Gao G, Zhao X, Fan H, Song B, Liu T, Zhang X, Guang X et al. Associations of changes in frailty with multiple chronic diseases in middle aged and elderly adults. (1471\u20132458 (Electronic))."},{"issue":"12","key":"3235_CR13","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1093\/eurheartj\/ehad885","volume":"45","author":"D He","year":"2024","unstructured":"He D, Wang Z, Li J, Yu K, He Y, He X, Liu Y, Li Y, Fu R, Zhou D, et al. Changes in frailty and incident cardiovascular disease in three prospective cohorts. Eur Heart J. 2024;45(12):1058\u201368.","journal-title":"Eur Heart J"},{"issue":"1","key":"3235_CR14","doi-asserted-by":"publisher","first-page":"28440","DOI":"10.1038\/s41598-025-14116-7","volume":"15","author":"X Zhang","year":"2025","unstructured":"Zhang X, Yang L, Jin Z, Li W, Xiang H, Wang W, Liang F. Frailty index is positively associated with stroke risk in nationally representative cohorts from the united States and China. Sci Rep. 2025;15(1):28440.","journal-title":"Sci Rep"},{"key":"3235_CR15","doi-asserted-by":"publisher","first-page":"1458542","DOI":"10.3389\/fnagi.2024.1458542","volume":"16","author":"J Zhou","year":"2024","unstructured":"Zhou J, Li Y, Zhu L, Yue R. Association between frailty index and cognitive dysfunction in older adults: insights from the 2011\u20132014 NHANES data. Front Aging Neurosci. 2024;16:1458542.","journal-title":"Front Aging Neurosci"},{"issue":"11","key":"3235_CR16","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1093\/gerona\/glad125","volume":"78","author":"T Ma","year":"2023","unstructured":"Ma T, He L, Luo Y, Fu D, Huang J, Zhang G, Cheng X, Bai Y. Frailty, An independent risk factor in progression trajectory of cardiometabolic multimorbidity: a prospective study of UK biobank. J Gerontol Biol Sci Med Sci. 2023;78(11):2127\u201335.","journal-title":"J Gerontol Biol Sci Med Sci"},{"issue":"12","key":"3235_CR17","doi-asserted-by":"publisher","first-page":"e650","DOI":"10.1016\/S2468-2667(20)30113-4","volume":"5","author":"J Fan","year":"2020","unstructured":"Fan J, Yu C, Guo Y, Bian Z, Sun Z, Yang L, Chen Y, Du H, Li Z, Lei Y, et al. Frailty index and all-cause and cause-specific mortality in Chinese adults: a prospective cohort study. Lancet Public Health. 2020;5(12):e650\u201360.","journal-title":"Lancet Public Health"},{"key":"3235_CR18","doi-asserted-by":"crossref","unstructured":"Huo G, Chen Y, Tang Y, Zhou D. Association between combined atherogenic and frailty index and cardiovascular events: evidence from the CHARLS cohort. Cardiovasc Diabetol 2025.","DOI":"10.1186\/s12933-025-03051-6"},{"key":"3235_CR19","unstructured":"von Elm E, Altman Dg Fau - Egger M, Egger M, Fau - Pocock SJ. Pocock Sj Fau - G\u00f8tzsche PC, G\u00f8tzsche Pc Fau - Vandenbroucke JP, Vandenbroucke JP: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. (1474-547X (Electronic))."},{"issue":"1","key":"3235_CR20","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s12933-024-02379-9","volume":"23","author":"P Zeng","year":"2024","unstructured":"Zeng P, Li M, Cao J, Zeng L, Jiang C, Lin F. Association of metabolic syndrome severity with frailty progression among Chinese middle and old-aged adults: a longitudinal study. Cardiovasc Diabetol. 2024;23(1):302.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3235_CR21","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12903-023-02853-y","volume":"23","author":"J Sun","year":"2023","unstructured":"Sun J, Guo G. Association between atherogenic index of plasma and periodontitis among U.S. adults. BMC Oral Health. 2023;23(1):166.","journal-title":"BMC Oral Health"},{"issue":"1","key":"3235_CR22","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s12933-025-02880-9","volume":"24","author":"YC Zhao","year":"2025","unstructured":"Zhao YC, Wu SQ, Li JK, Sun ZH, Zhang BK, Fu R, Yan M. Predictive value of the combined triglyceride-glucose and frailty index for cardiovascular disease and stroke in two prospective cohorts. Cardiovasc Diabetol. 2025;24(1):318.","journal-title":"Cardiovasc Diabetol"},{"key":"3235_CR23","unstructured":"Lai H, Tu Y, Liao C, Zhang S, He L, Li J. Joint assessment of abdominal obesity and non-traditional lipid parameters for primary prevention of cardiometabolic multimorbidity: insights from the China health and retirement longitudinal study 2011\u20132018. (1475\u20132840 (Electronic))."},{"key":"3235_CR24","unstructured":"Zhao YA-O, Zhuang Z, Li YA-O, Xiao W, Song Z, Huang N, Wang W, Dong X, Jia J, Clarke RA-O et al. Elevated blood remnant cholesterol and triglycerides are causally related to the risks of cardiometabolic multimorbidity. (2041\u2009\u2013\u20091723 (Electronic))."},{"key":"3235_CR25","unstructured":"Yang Y, Liu A. Associations of cumulative exposure and dynamic trajectories of the C-reactive protein-triglyceride-glucose index with incident stroke in middle-aged and older Chinese adults: a longitudinal analysis based on CHARLS. (1475\u20132840 (Electronic))."},{"issue":"21\u201322","key":"3235_CR26","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s00508-017-1264-1","volume":"129","author":"M Bendzala","year":"2017","unstructured":"Bendzala M, Sabaka P, Caprnda M, Komornikova A, Bisahova M, Baneszova R, Petrovic D, Prosecky R, Rodrigo L, Kruzliak P, et al. Atherogenic index of plasma is positively associated with the risk of all-cause death in elderly women: a 10-year follow-up. Wien Klin Wochenschr. 2017;129(21\u201322):793\u20138.","journal-title":"Wien Klin Wochenschr"},{"issue":"1","key":"3235_CR27","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12933-025-02618-7","volume":"24","author":"L Jiang","year":"2025","unstructured":"Jiang L, Zhu T, Song W, Zhai Y, Tang Y, Ruan F, Xu Z, Li L, Fu X, Liu D, et al. Assessment of six insulin resistance surrogate indexes for predicting stroke incidence in Chinese middle-aged and elderly populations with abnormal glucose metabolism: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24(1):56.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3235_CR28","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1186\/s12933-024-02532-4","volume":"23","author":"S Wu","year":"2024","unstructured":"Wu S, Gao Y, Liu W, Wang R, Ma Q, Sun J, Han W, Jia S, Du Y, Zhao Z, et al. The relationship between atherogenic index of plasma and plaque vulnerabilities: an optical coherence tomography study. Cardiovasc Diabetol. 2024;23(1):442.","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"3235_CR29","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.arcmed.2019.08.009","volume":"50","author":"JC Fern\u00e1ndez-Mac\u00edas","year":"2019","unstructured":"Fern\u00e1ndez-Mac\u00edas JC, Ochoa-Mart\u00ednez AC, Varela-Silva JA, P\u00e9rez-Maldonado IN. Atherogenic index of plasma: novel predictive biomarker for cardiovascular illnesses. Arch Med Res. 2019;50(5):285\u201394.","journal-title":"Arch Med Res"},{"issue":"1","key":"3235_CR30","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1186\/s12933-024-02449-y","volume":"23","author":"Y Zou","year":"2024","unstructured":"Zou Y, Lu S, Li D, Huang X, Wang C, Xie G, Duan L, Yang H. Exposure of cumulative atherogenic index of plasma and the development of prediabetes in middle-aged and elderly individuals: evidence from the CHARLS cohort study. Cardiovasc Diabetol. 2024;23(1):355.","journal-title":"Cardiovasc Diabetol"},{"key":"3235_CR31","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.atherosclerosis.2021.03.009","volume":"324","author":"KB Won","year":"2021","unstructured":"Won KB, Heo R, Park HB, Lee BK, Lin FY, Hadamitzky M, Kim YJ, Sung JM, Conte E, Andreini D, et al. Atherogenic index of plasma and the risk of rapid progression of coronary atherosclerosis beyond traditional risk factors. Atherosclerosis. 2021;324:46\u201351.","journal-title":"Atherosclerosis"},{"issue":"1","key":"3235_CR32","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s12933-023-02044-7","volume":"22","author":"H Zheng","year":"2023","unstructured":"Zheng H, Wu K, Wu W, Chen G, Chen Z, Cai Z, Cai Z, Lan Y, Wu S, Chen Y. Relationship between the cumulative exposure to atherogenic index of plasma and ischemic stroke: a retrospective cohort study. Cardiovasc Diabetol. 2023;22(1):313.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3235_CR33","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12933-025-02732-6","volume":"24","author":"Y Liu","year":"2025","unstructured":"Liu Y, Li W, Zhou H, Zeng H, Jiang J, Wang Q, Liu T, Liu X, Chen P, Zhong X. Association between atherogenic index of plasma and new-onset stroke in a population with cardiovascular-kidney-metabolic syndrome stages 0\u20133: insights from CHARLS. Cardiovasc Diabetol. 2025;24(1):168.","journal-title":"Cardiovasc Diabetol"},{"issue":"12","key":"3235_CR34","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1016\/j.hrthm.2025.01.004","volume":"22","author":"L Cai","year":"2025","unstructured":"Cai L, Sun Y, Zhu J, Wang B, Tan X, Shi W, Xu D, Wang Y, Lu Y, Wang N. Long-term changes in frailty and incident atrial fibrillation, heart failure, coronary heart disease, and stroke: a prospective follow-up study. Heart Rhythm. 2025;22(12):3090\u20138.","journal-title":"Heart Rhythm"},{"key":"3235_CR35","doi-asserted-by":"crossref","unstructured":"Burton JK, Stewart J, Blair M, Oxley S, Wass A, Taylor-Rowan M, Quinn TJ. Prevalence and implications of frailty in acute stroke: systematic review & meta-analysis. Age Ageing 2022;51(3).","DOI":"10.1093\/ageing\/afac064"},{"key":"3235_CR36","doi-asserted-by":"publisher","first-page":"1592565","DOI":"10.3389\/fneur.2025.1592565","volume":"16","author":"Y Song","year":"2025","unstructured":"Song Y, Liu J, Wang S, Shi H, Han L. Association between frailty trajectories and stroke incidence among Chinese older adults: evidence from CHARLS 2011\u20132015. Front Neurol. 2025;16:1592565.","journal-title":"Front Neurol"},{"key":"3235_CR37","unstructured":"Mukamal KJ, Siscovick DS, de Boer IH, Ix JH, Kizer JR, Djouss\u00e9 L, Fitzpatrick AL, Tracy RP, Boyko EJ, Kahn SE et al. Metabolic clusters and outcomes in older adults: the cardiovascular health study. (1532\u20135415 (Electronic))."},{"key":"3235_CR38","unstructured":"Donato AJ, Machin DR, Lesniewski LA. Mechanisms of dysfunction in the aging vasculature and role in age-related disease. (1524\u20134571 (Electronic))."},{"issue":"1","key":"3235_CR39","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1186\/s12944-025-02793-2","volume":"24","author":"XW Li","year":"2025","unstructured":"Li XW, Shuai P, Huang XC, Mou Y, He PY. Atherogenic index of plasma and subclinical vascular disease: predictive value for coronary and carotid atherosclerosis in a health screening population. Lipids Health Dis. 2025;24(1):369.","journal-title":"Lipids Health Dis"},{"issue":"9","key":"3235_CR40","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1093\/cvr\/cvae073","volume":"120","author":"R Sato","year":"2024","unstructured":"Sato R, Vatic M, Peixoto da Fonseca GW, Anker SD, von Haehling S. Biological basis and treatment of frailty and sarcopenia. Cardiovasc Res. 2024;120(9):982\u201398.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"3235_CR41","doi-asserted-by":"publisher","first-page":"103106","DOI":"10.1016\/j.arcmed.2024.103106","volume":"56","author":"SG Aguilar-Navarro","year":"2025","unstructured":"Aguilar-Navarro SG, Mimenza-Alvarado AJ, Yeverino-Castro SG, Caicedo-Correa SM, Cano-Guti\u00e9rrez C. Cognitive frailty and aging: clinical characteristics, pathophysiological mechanisms, and potential prevention strategies. Arch Med Res. 2025;56(1):103106.","journal-title":"Arch Med Res"},{"issue":"1","key":"3235_CR42","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12933-025-02597-9","volume":"24","author":"H Tian","year":"2025","unstructured":"Tian H, Li YM, Wang CQ, Chen GQ, Lian Y. Association between non-insulin-based insulin resistance indicators and frailty progression: a national cohort study and mendelian randomization analysis. Cardiovasc Diabetol. 2025;24(1):31.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3235_CR43","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.1186\/s12889-024-20908-9","volume":"24","author":"S Han","year":"2024","unstructured":"Han S, Zhang Z, Cheng S, Han Y, Wang Q, Xi Y, Li P, Li F, Guo J. Correlations between frailty index and inflammatory markers derived from blood cell count in the United States. BMC Public Health. 2024;24(1):3408.","journal-title":"BMC Public Health"},{"issue":"1","key":"3235_CR44","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.mcna.2022.04.006","volume":"107","author":"CI Cohen","year":"2023","unstructured":"Cohen CI, Benyaminov R, Rahman M, Ngu D, Reinhardt M. Frailty: a multidimensional biopsychosocial syndrome. Med Clin North Am. 2023;107(1):183\u201397.","journal-title":"Med Clin North Am"},{"issue":"5","key":"3235_CR45","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.cmet.2012.04.001","volume":"15","author":"CK Glass","year":"2012","unstructured":"Glass CK, Olefsky JM. Inflammation and lipid signaling in the etiology of insulin resistance. Cell Metab. 2012;15(5):635\u201345.","journal-title":"Cell Metab"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-026-03235-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03235-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03235-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:05:34Z","timestamp":1786539934000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12933-026-03235-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,6]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3235"],"URL":"https:\/\/doi.org\/10.1186\/s12933-026-03235-8","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,6]]},"assertion":[{"value":"24 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The CHARLS protocol was approved by the Ethical Review Committee at Peking University (IRB0000105211015). Prior to participation, all study subjects provided written informed consent.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"228"}}